Legal & General Group
GPCR icon

Legal & General Group’s Structure Therapeutics GPCR Stock Holding History

Legal & General Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-612
Closed -$17.1K – 3402
2025
Q3 		$17.1K Buy
+612
New +$12.2K ﹤0.01% 3107

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Legal & General Group's GPCR Position: Q4 2025 in Review

Legal & General Group sold out of Structure Therapeutics (GPCR) in Q4 2025, closing a stake of 612 shares — an estimated $17.1K sold.

Legal & General Group first reported a position in GPCR in Q3 2025 and held it in 1 quarter. The position peaked at $17.1K in Q3 2025. 197 funds tracked by Wall St. Rank hold GPCR as of Q4 2025.

  • Legal & General Group reported no remaining Structure Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Legal & General Group sold 612 Structure Therapeutics shares in Q4 2025, an estimated $17.1K.
  • Legal & General Group first reported a position in Structure Therapeutics in Q3 2025 and held it in 1 quarter.
  • Legal & General Group's Structure Therapeutics position peaked at $17.1K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2025.

Based on Legal & General Group's 13F filing for Q4 2025, filed 9 Feb 2026.